Aida Pharmaceuticals reported that Chinese officials have loosened restrictions on Etimicin Sulfate, the company’s new generation of aminoglycoside antibiotic. Etimicin Sulfate, the first antibiotic to be developed in China, is a broad spectrum antibiotic used for serious infections. In its various forms (powder, injection, infusion), the antibiotic provides all of Aida’s revenues.  We look at the company and its main product...

Stock Symbol: (OTCBB: AIDA)